Skip to main content
    V

    Virax Biolabs Group Limited Ordinary Shares (VRAX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.45
    -0.00 (-0.65%)

    Market Cap: $823,940

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Virax Biolabs Group Limited Ordinary Shares (VRAX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Virax Biolabs Group Limited Ordinary Shares (VRAX) has a latest price of $0.45 on Nov 17, 2026, 98.0% below its 52-week high of $21.75. Its price fell 96.4% over the past 12 months. The month-end price fell 98.0% over the 3 years through Oct 2026, a compound annual decline of 73.0%.

    Price Chart

    From Jul 2022 to Oct 2026, its highest month-end close was $1,350.00 in Jul 2022 and its lowest $1.21 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VRAX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VRAX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 86.0%, and over 6 months it fell 94.2%.

    PeriodChange
    1 month-68.2%
    3 months-86.0%
    6 months-94.2%
    12 months-96.4%
    12 months, with dividends-96.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-98.0%-73.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 54.1%, and its weakest was 2025, when it fell 84.6%.

    YearCloseChange
    2026 through Oct 2026$1.21-86.0%
    2025$8.64-84.6%
    2024$56.25+54.1%
    2023$36.50-80.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 73.9% below its 50-day average of $1.70 and 87.4% below its 200-day average of $3.53.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.45
    52-week high$21.75-98.0%
    52-week low$0.40+11.3%
    50-day average$1.70-73.9%
    200-day average$3.53-87.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.7%.

    MeasureValue
    1-year beta1.92
    Largest fall, 1 year-97.4%
    Largest fall, 3 years-99.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VRAX

    What is VRAX's 1-year price change?

    Virax Biolabs Group Limited Ordinary Shares's price fell 96.4% over the past 12 months. With dividends included, the 12-month total return was -96.4%.

    How has VRAX stock done over the long term?

    Virax Biolabs Group Limited Ordinary Shares's month-end price fell 98.0% over the 3 years through Oct 2026, a compound annual decline of 73.0%. These figures leave out dividends.

    What is VRAX's 52-week high and low?

    Virax Biolabs Group Limited Ordinary Shares's 52-week high is $21.75 and its 52-week low is $0.40. Its latest price of $0.45 on Nov 17, 2026 is 98.0% below the high.

    What is VRAX's beta?

    Virax Biolabs Group Limited Ordinary Shares's 1-year beta against the S&P 500 is 1.92, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 97.4%.

    Is the VRAX chart free?

    Yes. Advanced Charting for VRAX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.